Free Newsletter
Sanofi: No 'major' U.S. deal presented to board
Hearing rumors that Sanofi-Aventis was looking at a "major" U.S. acquisition? Well, Sanofi denied it presented said acquisition plan to its board, after Les Echos newspaper reported that the drugmaker's major shareholders had deemed the deal too risky. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: